Thursday, November 7, 2019 |
|
SCIENTIFIC INFORMATION |
|
12:45pm - 2:00pm |
BREAKOUT SESSIONSState of PharmacogeneticsClinical Implementation of Pharmacogenomics Philip Empey, PharmD, PhD, University of Pittsburgh, UPMC, Pittsburg, PA, USA What’s New in Pharmacogenetics? Victoria M. Pratt. PhD, Indiana University School of Medicine, Indianapolis, IN, USA Reimbursement: It’s Never too Late to Start Getting PaidAnthony Sireci, MD, Loxo Oncology, Stamford, CT, USA Aaron Bossler, MD, PhD, University of Iowa, Iowa City, IA, USA Demystifying Molecular testing coverage and policies: MolDX and Medicare Gabriel Bien-Willner. MD, PhD, Palmetto GBA, TX, USA Biobanking and 3D-Organoid TechnologyPerspective on Establishing a Biorepository for Clinical and Research Use Kristy Crooks, PhD, University of Colorado, Aurora, CO, USA Profiling the DNA Damage Repair Capacity of High Grade Serous Ovarian Tumors using Patient-Derived Organoids Sarah Hill, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, USA |
3:45pm - 4:30pm |
CONCURRENT SPECIAL SESSIONSAMP CPC’s In Silico Reference Materials Working Group: Update & Open Comment ForumEric Duncavage, MD, Washington University, Saint Louis, MO, USA Justin Zook, PhD, National Inst of Standards & Tech, Gaithersburg, MD, USA |
Friday, November 8, 2019 |
|
SCIENTIFIC INFORMATION |
|
10:45am - 12:15pm |
CONCURRENT SPECIAL SESSIONSPicking a LIMS SystemDo-It-Yourself Molecular LIMS Long P. Le, MD, PhD, Massachusetts General Hospital, Charlestown, MA, USA Kristina Cusmano-Ozog, MD, Children’s National, Palo Alto, CA, USA Development of a Laboratory Information System to Support Clinical NGS Testing Michael Kluk, MD, PhD, Weill Cornell Medicine, New York, NY, USA Process Validation and Quality Assurance Around the WorldESP Molecular Pathology WG: Diagnosis and Clinical Research Reproducibility Giorgio Stanta, MD, PhD, University of Trieste, Duino-Aurisina, Italy Quality Assessment Experience in Brazil Roberta Sitnik, MSc, PhD, Departamento de Patologia Clínica e Anatomia Patológica, São Paulo, Brazil |
1:30pm - 2:45pm |
BREAKOUT SESSIONSPractical Approaches to Centralizing (or Decentralizing) Molecular TestingCentralized Testing in Molecular Pathology via Lean Laboratory Design John Longshore, PhD, Carolinas Pathology Group, Charlotte, NC, USA Molecular Laboratory Organization: the University of Washington Experience Daniel E. Sabath, MD, PhD, University of Washington School of Medicine, Seattle, WA, USA Point Counterpoint: Who Owns Molecular Infectious Disease Testing?Frederick Nolte, PhD, Medical Univ of South Carolina, Charleston, SC, USA
Nathan Ledeboer, PhD, Medical College of Wisconsin, Milwaukee, WI, USA New Players in Reimbursement: Laboratory Benefit Managers(Sponsored by the AMP Economic Affairs Committee)Panel Discussion Geoffrey Baird, MD, PhD, University of Washington, Seattle, Washington, USA Trish Brown, MS, LCGC, Illumina, Inc., San Diego, CA, USA Heather Agostinelli, Xifin, Inc., San Diego, CA, USA |
4:00pm - 5:00pm |
PLENARY SESSIONClimate Change & Global SurveillanceArturo Casadevall, MD, PhD, Johns Hopkins, Baltimore, MD, USA |
Saturday, November 9, 2019 |
|
SCIENTIFIC INFORMATION |
|
7:00am - 8:00am |
TARGETED TOPICSIntegrating Genomics into the EHRBarriers to Integrating Genomics More Fully into the EHR Brian Shirts, MD, PhD, University of Washington, Seattle, WA, US |
1:30pm - 2:45pm |
BREAKOUT SESSIONSThe Future of the AMP v. Myriad Decision: Exploring Potential Impacts on Multigene Panel Testing and Patient Care(Sponsored by the AMP Professional Relations Committee) Panel Discussion Charles Duan, JD, The R Street Institute, Washington, DC, USA |